Follow
Nantia Othonos
Nantia Othonos
Addenbrooke's hospital
Verified email at addenbrookes.nhs.uk
Title
Cited by
Cited by
Year
Who should be considered for islet transplantation alone?
N Othonos, P Choudhary
Current diabetes reports 17, 1-7, 2017
192017
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial
N Othonos, R Pofi, A Arvaniti, S White, I Bonaventura, N Nikolaou, ...
Nature Communications 14 (1), 1025, 2023
122023
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
JM Hazlehurst, TR Lim, C Charlton, JJ Miller, LL Gathercole, T Cornfield, ...
Metabolism open 14, 100177, 2022
92022
Co-administration of 5α-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids
N Othonos, T Marjot, C Woods, JM Hazlehurst, N Nikolaou, R Pofi, ...
The Journal of Clinical Endocrinology & Metabolism 105 (9), e3316-e3328, 2020
92020
Glucocorticoid metabolism and activation
N Othonos, J Tomlinson
Academic Press, 2019
42019
11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: a randomized, double-blind, placebo …
N Othonos, R Pofi, A Arvaniti, A Whittaker, P Stewart, R Coleman, ...
Endocrine Abstracts 70, 2020
12020
The outcome of dapagliflozin use in a reallife clinical setting in multi-district general hospitals
RB Kannan, N Othonos, G Dimitriadis, T Barber, N Murthy, J Young, ...
DIABETIC MEDICINE 32, 173-173, 2015
12015
11 [beta]-hydroxysteroid dehydrogenase type 1 inhibition unmasks multiple pathways that may mitigate the adverse effects of prescribed prednisolone
R Pofi, S Coll, N Othonos, H Miller, T Potter, J Escott, A Whittaker, ...
Endocrine Abstracts 99, 2024
2024
Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition
C Gómez, Z Alimajstorovic, N Othonos, DV Winter, S White, GG Lavery, ...
British Journal of Pharmacology 181 (5), 698-711, 2024
2024
Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition
CG Castella, Z Alimajstorovic, N Othonos, D Winter, S White, G Lavery, ...
Authorea Preprints, 2023
2023
The impact of pre-receptor metabolism on the adverse effects of exogenous glucocorticoids
N Othonos
University of Leeds, 2020
2020
Co-administration of 5 [alpha]-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids
T Marjot, N Othonos, C Woods, J Hazlehurst, A Moolla, L Hodson, ...
Endocrine Abstracts 50, 2017
2017
The adverse effects of prescribed glucocorticoids are worsened by co-administration of 5 [alpha]-reductase inhibitors
T Marjot, N Othonos, C Woods, J Hazlehurst, A Moola, L Hodson, ...
Endocrine Abstracts 49, 2017
2017
Continuous intra-peritoneal insulin infusion: an alternative option for insulin administration
N Othonos, S Khorsandi, A Pernet, G Gallen, P Srinivasan, P Choudhary
DIABETIC MEDICINE 34, 16-16, 2017
2017
Clinical care and other categories posters
N Othonos, S Khorsandi, A Pernet, G Gallen, P Srinivasan, P Choudhary, ...
2017
A comparative study of women with gestational diabetes vs a high risk group without gestational diabetes and their antenatal and neonatal outcomes
N Othonos, G Dimitriadis, C Sherry, R Rao, W Goodwin, S Eastman, ...
DIABETIC MEDICINE 32, 177-177, 2015
2015
Diabetes: the forgotten complication of parathyroidectomy
N Othonos, V Patel, R Nair, S Ayre, P Saravanan
Endocrine Abstracts 34, 2014
2014
Type 1 diabetes+ metabolic syndrome: need for a different management paradigm?
N Othonos, V Patel, P Saravanan
DIABETIC MEDICINE 31, 181-181, 2014
2014
Audit of the management of diabetic ketoacidosis in a large teaching hospital, before adoption of national guidelines
K Seejore, MH Bholah, SE Jones, S Drake, N Othonos, A Abbas
DIABETIC MEDICINE 30, 81-82, 2013
2013
Suboptimal control on metformin and sulfonylurea: what next?
N Othonos, A Abbas
Prescriber 24 (3), 15-20, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20